Table 1.
Demographic and clinical characteristics of 39 patients with COVID-19.
| Characteristics (normal range) | Median (IQR) / N (%) | Increased, N (%) | Decreased, N (%) |
|---|---|---|---|
| Age, year | 53 (41–61) | – | – |
| Sex | |||
| Female | 20 (51.3) | – | – |
| Male | 19 (48.7) | – | – |
| Onset to admission, d | 5 (3–7) | – | – |
| Leucocytes (3.5–9.5 × 10⁹/L) | 4.11 (3.33–5.16) | 13 (34.2) | 3 (7.9) |
| Lymphocytes (1.1–3.2 × 10⁹/L) | 0.73 (0.56–1.07) | 0 | 29 (76.3) |
| T cells (805–4459 × 106/L) | 561.0 (300.0–1056.0) | 0 | 24 (61.5) |
| CD4+ T cells (345–2350 × 106/L) | 308.0 (176.0–665.0) | 0 | 22 (56.4) |
| CD8+ T cells (345–2350 × 106/L) | 168.0 (117.0–368.0) | 0 | 28 (71.8) |
| CD4+/CD8+ (0.96–2.05) | 1.640 (1.140–2.380) | 14 (35.9) | 7 (17.9) |
| B cells (240–1317 × 106/L) | 146.0 (56.0–272.0) | 0 | 27 (69.2) |
| NK cells (210–1514 × 106/L) | 136.0 (57.0–207.0) | 0 | 30 (76.9) |
| Onset to RT-PCR turning negative, d | 14 (10–20) | – | – |